Drug Labeling < Drug Monitoring < Drug Prescriptions

Facettes : Author.f AffPays.f Mesh.f AffRegion.f AffVille.f AffOrg.f

List of bibliographic references

Number of relevant bibliographic references: 25.
[0-20] [0 - 20][0 - 25][20-24][20-40]

Ident.	Authors (with country if any)	Title
000328 (2019)	C. Turesson [Suède] ; O. Börjesson [Suède] ; K. Larsson [Suède] ; A J Mohammad [Suède] ; A. Knight [Suède]	Swedish Society of Rheumatology 2018 guidelines for investigation, treatment, and follow-up of giant cell arteritis.
000533 (2019)	Jacques-Eric Gottenberg [France] ; Jacques Morel [France] ; Elodie Perrodeau [France] ; Thomas Bardin [France] ; Bernard Combe [France] ; Maxime Dougados [France] ; Rene-Marc Flipo [France] ; Alain Saraux [France] ; Thierry Schaeverbeke [France] ; Jean Sibilia [France] ; Martin Soubrier [France] ; Olivier Vittecoq [France] ; Gabriel Baron [France] ; Arnaud Constantin [France] ; Philippe Ravaud [France] ; Xavier Mariette [France]	Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study.
000581 (2019)	Noriko Iwamoto [États-Unis] ; Atsushi Yonezawa [Japon] ; Kazuo Matsubara [Japon] ; Takashi Shimada [États-Unis]	Acceleration of nano-surface and molecular-orientation limited (nSMOL) proteolysis with acidified reduction pretreatment for quantification of Tocilizumab.
000586 (2019)	Théo Willeman [France] ; Jean-François Jourdil [France] ; Elodie Gautier-Veyret [France] ; Bruno Bonaz [France] ; Françoise Stanke-Labesque [France]	A multiplex liquid chromatography tandem mass spectrometry method for the quantification of seven therapeutic monoclonal antibodies: Application for adalimumab therapeutic drug monitoring in patients with Crohn's disease.
000895 (2018)	Karien Bloem [Pays-Bas] ; Tiny Schaap [Pays-Bas] ; Ronald Boshuizen [Pays-Bas] ; Eva L. Kneepkens [Pays-Bas] ; Gerrit J. Wolbink [Pays-Bas] ; Annick De Vries [Pays-Bas] ; Theo Rispens [Pays-Bas]	Capillary blood microsampling to determine serum biopharmaceutical concentration: Mitra® microsampler vs dried blood spot.
000971 (2017)	Naohiro Motozawa [Japon] ; Takahiro Nakamura ; Seiji Takagi ; Masashi Fujihara ; Yasuhiko Hirami ; Kazuhiro Ishida ; Chie Sotozono ; Yasuo Kurimoto	Unique circumferential peripheral keratitis in relapsing polychondritis: A case report.
000A29 (2017)	Shoichi Kaneshiro [Japon] ; Kosuke Ebina [Japon] ; Makoto Hirao [Japon] ; Hideki Tsuboi [Japon] ; Masataka Nishikawa [Japon] ; Akihide Nampei [Japon] ; Yoshio Nagayama [Japon] ; Koichiro Takahi ; Takaaki Noguchi [Japon] ; Hajime Owaki [Japon] ; Jun Hashimoto [Japon] ; Hideki Yoshikawa [Japon]	The efficacy and safety of additional administration of tacrolimus in patients with rheumatoid arthritis who showed an inadequate response to tocilizumab.
000A64 (2017)	E L Kneepkens [Pays-Bas] ; Iam Van Den Oever [Pays-Bas] ; C H Plasencia [Espagne] ; D. Pascual-Salcedo [Espagne] ; A. De Vries [Pays-Bas] ; M. Hart [Pays-Bas] ; M T Nurmohamed [Pays-Bas] ; A. Balsa [Espagne] ; T. Rispens [Pays-Bas] ; G. Wolbink [Pays-Bas]	Serum tocilizumab trough concentration can be used to monitor systemic IL-6 receptor blockade in patients with rheumatoid arthritis: a prospective observational cohort study.
000B80 (2017)	Shunsei Hirohata [Japon] ; Asami Abe [Japon] ; Akira Murasawa [Japon] ; Toshihisa Kanamono ; Tetsuya Tomita [Japon] ; Hideki Yoshikawa [Japon]	Differential effects of IL-6 blockade tocilizumab and TNF inhibitors on angiogenesis in synovial tissues from patients with rheumatoid arthritis.
000B88 (2017)	Sara Murias [France] ; Lorena Magallares ; Fatima Albizuri ; Dora Pascual-Salcedo ; Erwin Dreesen ; Denis Mulleman	Current Practices for Therapeutic Drug Monitoring of Biopharmaceuticals in Pediatrics.
000B89 (2017)	Frédéric Medina [Espagne] ; Chamaida Plasencia ; Philippe Goupille ; David Ternant ; Alejandro Balsa ; Denis Mulleman	Current Practice for Therapeutic Drug Monitoring of Biopharmaceuticals in Rheumatoid Arthritis.
000D88 (2016)	Bart V J. Cuppen [Pays-Bas] ; Paco M J. Welsing [Pays-Bas] ; Jan J. Sprengers [Pays-Bas] ; Johannes W J. Bijlsma [Pays-Bas] ; Anne C A. Marijnissen [Pays-Bas] ; Jacob M. Van Laar [Pays-Bas] ; Floris P J G. Lafeber [Pays-Bas] ; Sandhya C. Nair [Pays-Bas]	Personalized biological treatment for rheumatoid arthritis: a systematic review with a focus on clinical applicability.
000E21 (2016)	Tadashi Okano [Japon] ; Kentaro Inui [Japon] ; Masahiro Tada [Japon] ; Yuko Sugioka [Japon] ; Kenji Mamoto [Japon] ; Shigeyuki Wakitani [Japon] ; Tatsuya Koike [Japon] ; Hiroaki Nakamura [Japon]	Levels of interleukin-1 beta can predict response to tocilizumab therapy in rheumatoid arthritis: the PETITE (predictors of effectiveness of tocilizumab therapy) study.
000F23 (2016)	Patrick D W. Kiely [Royaume-Uni]	Biologic efficacy optimization--a step towards personalized medicine.
000F52 (2015)	A. Rubbert-Roth [Allemagne]	[Switching within the active ingredient group or changing the mechanism of action. Data situation by failure of the first line biologic].
001231 (2014)	K. Takase [Royaume-Uni] ; S C Horton [Royaume-Uni] ; A. Ganesha [Royaume-Uni] ; S. Das [Royaume-Uni] ; A. Mchugh [Royaume-Uni] ; P. Emery [Royaume-Uni] ; S. Savic [Royaume-Uni] ; M H Buch [Royaume-Uni]	What is the utility of routine ANA testing in predicting development of biological DMARD-induced lupus and vasculitis in patients with rheumatoid arthritis? Data from a single-centre cohort.
001605 (2013)	Josef S. Smolen [Autriche] ; Monika M. Schoels ; Norihiro Nishimoto ; Ferdinand C. Breedveld ; Gerd R. Burmester ; Maxime Dougados ; Paul Emery ; Gianfranco Ferraccioli ; Cem Gabay ; Allan Gibofsky ; Juan Jesus Gomez-Reino ; Graeme Jones ; Tore K. Kvien ; Miho Murakami ; Neil Betteridge ; Clifton O. Bingham ; Vivian Bykerk ; Ernest H. Choy ; Bernard Combe ; Maurizio Cutolo ; Winfried Graninger ; Angel Lanas ; Emilio Martin-Mola ; Carlomaurizio Montecucco ; Mikkel Ostergaard ; Karel Pavelka ; Andrea Rubbert-Roth ; Naveed Sattar ; Marieke Scholte-Voshaar ; Yoshiya Tanaka ; Michael Trauner ; Gabriele Valentini ; Kevin L. Winthrop ; Maarten De Wit ; Désirée Van Der Heijde	Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions.
001732 (2012)	Bertalan Mesko [Hongrie] ; Szilard Poliska ; Szilvia Szamosi ; Zoltan Szekanecz ; Janos Podani ; Csaba Varadi ; Andras Guttman ; Laszlo Nagy	Peripheral blood gene expression and IgG glycosylation profiles as markers of tocilizumab treatment in rheumatoid arthritis.
001B78 (2007)	Cécile Fournel ; Mehdi Medjoub ; Samuel Limat ; Marie-Christine Woronoff-Lemsi	[2/2 The other biotherapies].
001D26 (????)	Roberta Gualtierotti [Italie] ; Francesca Ingegnoli [Italie] ; Samantha Griffini [Italie] ; Elena Grovetti [Italie] ; Pier Luigi Meroni [Italie] ; Massimo Cugno [Italie]	Prothrombotic biomarkers in patients with rheumatoid arthritis: the beneficial effect of IL-6 receptor blockade.
001D27 (????)	Florenzo Iannone [Italie] ; Marilina Tampoia [Italie] ; Margherita Giannini [Italie] ; Giuseppe Lopalco [Italie] ; Luca Cantarini [Italie] ; C Danilo Villalta [Italie] ; Mauro Galeazzi [Italie] ; Giovanni Lapadula [Italie]	Changes in anti-cyclic citrullinated peptide antibodies and rheumatoid factor isotypes serum levels in patients with rheumatoid arthritis following treatment with different biological drugs.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i -k "Drug Monitoring" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i  \
                -Sk "Drug Monitoring" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Drug Monitoring
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021